MCMedicalCodingSoftware
3E0X3BZ

3E0X3BZIntroduction of Anesthetic Agent into Cranial Nerves, Percutaneous Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduction of Anesthetic into Cranial Nrv, Perc Approach

How 3E0X3BZ is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. XBody partThe specific site
  5. 3ApproachHow the site was reached
  6. BDeviceWhat was left in place, if anything
  7. ZQualifierA further distinction where one applies

Codes near 3E0X3BZ

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0W37ZIntroduction of Electrolytic and Water Balance Substance into Lymphatics, Percutaneous Approach
  • 3E0W3BZIntroduction of Anesthetic Agent into Lymphatics, Percutaneous Approach
  • 3E0W3GCIntroduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach
  • 3E0W3HZIntroduction of Radioactive Substance into Lymphatics, Percutaneous Approach
  • 3E0W3KZIntroduction of Other Diagnostic Substance into Lymphatics, Percutaneous Approach
  • 3E0W3NZIntroduction of Analgesics, Hypnotics, Sedatives into Lymphatics, Percutaneous Approach
  • 3E0W3TZIntroduction of Destructive Agent into Lymphatics, Percutaneous Approach
  • 3E0X33ZIntroduction of Anti-inflammatory into Cranial Nerves, Percutaneous Approach
  • 3E0X3BZIntroduction of Anesthetic Agent into Cranial Nerves, Percutaneous Approach
  • 3E0X3GCIntroduction of Other Therapeutic Substance into Cranial Nerves, Percutaneous Approach
  • 3E0X3TZIntroduction of Destructive Agent into Cranial Nerves, Percutaneous Approach
  • 3E0Y304Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Percutaneous Approach
  • 3E0Y305Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach
  • 3E0Y30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach
  • 3E0Y328Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach
  • 3E0Y329Introduction of Other Anti-infective into Pericardial Cavity, Percutaneous Approach
  • 3E0Y33ZIntroduction of Anti-inflammatory into Pericardial Cavity, Percutaneous Approach
ICD-10-PCSFY2026